Podcast: Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer

Stomach cancer is the fifth most common cancer and third leading cause of cancer-related deaths worldwide. Molecular-targeted therapy is one of the newer treatments and a new Cochrane Review in July 2016 looks at the evidence from randomized trials. Lead author, Huan Song from the Karolinska Institutet in Sweden, tells us more in this Evidence Pod.